During the past decade, Hematology and Oncology Associates-Oakland conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 35 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology and Oncology Associates-Oakland" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "Celgene" with 1 trials sponsored and "Clovis Oncology, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology and Oncology Associates-Oakland" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hematology and Oncology Associates-Oakland" are "Recurrent Breast Carcinoma" (8 trials), "Stage IIIB Breast Cancer AJCC v7" (6 trials), "Stage IIIC Breast Cancer AJCC v7" (6 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (5 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Hematology and Oncology Associates-Oakland" in a lesser frequency.

Most popular intervention types in "Hematology and Oncology Associates-Oakland" are "Drug" (50 trials), "Other" (40 trials), "Biological" (24 trials), "Radiation" (10 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Bevacizumab" (15 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Hematology and Oncology Associates-Oakland" are 42 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Hematology and Oncology Associates-Oakland". undefined are not yet recruiting, 3 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Hematology and Oncology Associates-Oakland, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology and Oncology Associates-Oakland, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".